FDA 510(k)

Isolator® Synergy™ EnCompass Clamp and Guide system (OLH, OSH, GPM100)

N.º K: K252056 · 2025-07-24

Fecha de decisión2025-07-24

Código de productoOCL

Comité asesorSU

DecisiónSubstantially Equivalent

Resumen del dispositivo

Isolator® Synergy™ EnCompass Clamp and Guide system (OLH, OSH, GPM100) is the device name listed in this FDA 510(k) record. The listed applicant is AtriCure, Inc.. It received FDA 510(k) clearance on 2025-07-24 under 510(k) number K252056. The device is classified under product code OCL. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the Isolator® Synergy™ EnCompass Clamp and Guide system (OLH, OSH, GPM100)?

Isolator® Synergy™ EnCompass Clamp and Guide system (OLH, OSH, GPM100) is a medical device that received FDA 510(k) clearance on 2025-07-24. The listed applicant is AtriCure, Inc.. The 510(k) number is K252056.

When did Isolator® Synergy™ EnCompass Clamp and Guide system (OLH, OSH, GPM100) receive FDA 510(k) clearance?

Isolator® Synergy™ EnCompass Clamp and Guide system (OLH, OSH, GPM100) received FDA 510(k) clearance on 2025-07-24, under 510(k) number K252056.

Who is the listed applicant for Isolator® Synergy™ EnCompass Clamp and Guide system (OLH, OSH, GPM100)?

The FDA 510(k) record lists AtriCure, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Isolator® Synergy™ EnCompass Clamp and Guide system (OLH, OSH, GPM100)?

The FDA product code for Isolator® Synergy™ EnCompass Clamp and Guide system (OLH, OSH, GPM100) is OCL.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Otros registros que enlistan a AtriCure, Inc. como solicitante

K250371cryoICE cryoXT cryoablation probe (cryoXT)K243860AtriClip PRO-Mini LAA Exclusion System (PROM)K243157AtriCure cryoICE BOX (ACM)K234151Isolator Synergy EnCapture Ablation System (EMH)K234125AtriClip FLEX-Mini LAA Exclusion System (ACHM)K233959EPi-Ease Epicardial Access Device (EAS)

Ver todos los 32 dispositivos →

Dispositivos relacionados (Código: OCL)

K234151Isolator Synergy EnCapture Ablation System (EMH)AtriCure, Inc.K221358Isolator® Linear Pen (MLP1); Isolator® Transpolar™ Pen (MAX1, MAX5), Coolrail® Linear Pen (MCR1); Isolator® Synergy Surgical Ablation System (EMR2, EML2); Isolator® Synergy™ EnCompass Clamp (OLH, OSH) and Guide System; Isolator® Synergy Access Clamp (EMT1)AtriCure, Inc.K223508Cardioblate Gemini-s 49260 Surgical Ablation Device; Cardioblate Gemini-s 49351 Surgical Ablation DeviceMedtronic, Inc.K210477AtriCure Isolator Encompass Ablation System, GLIDEPATH Magnetic GUIDEAtriCure, Inc.K211311AtriCure Isolator® Synergy™ Surgical Ablation SystemAtriCure, Inc.K200514Cardioblate Gemini-s Surgical Ablation DeviceMedtronic

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.